1301 Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus- prone MRL/lpr mice | Lupus Science & Medicine

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Lupus Clinical Trials

1301 Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus- prone MRL/lpr mice

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Cabana-Puig X, Mu Q, Lu R, et al

1301 Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus- prone MRL/lpr mice

Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-lupus21century.91